Business Context and Reporting Period
This Form 6-K filing by Globant S.A. covers the period of February 2020, specifically dated February 6, 2020. The report details a significant corporate finance transaction involving Globant, LLC, the U.S. subsidiary of the Company.
Key Financial Metrics and Debt Structure
The filing focuses on the restructuring of the Company's credit facilities rather than operational financial performance metrics such as revenue or profit.
- Revolving Credit Facility: Increased to a maximum of $250 million (up from $150 million).
- Delayed-Draw Term Loan Facility: Established at up to $100 million, available in up to four borrowings on or prior to August 6, 2021 (replacing a previous $50 million facility).
- Expansion Option: The Borrower may request increases to the revolving facility up to an additional $100 million.
- Maturity Date: February 5, 2025, for both facilities.
- Interest Rates: LIBOR plus 1.50% or LIBOR plus 1.75%, determined by the Maximum Total Leverage Ratio.
- Collateral and Guarantees: Obligations are guaranteed by Globant S.A. and Globant España S.A., secured by substantially all assets of the Borrower.
The filing text does not provide clear values for revenue, profit, cash flow, margins, or current liquidity positions.
Material Changes Versus Prior Period
The Second Amended and Restated Credit Agreement replaces the Amended and Restated Credit Agreement dated November 1, 2018. Key changes include:
- Capacity Increase: The revolving credit facility capacity increased by $100 million.
- Term Loan Restructuring: The delayed-draw term loan capacity increased from $50 million to $100 million, with a new draw deadline of August 6, 2021.
- Extended Maturity: The maturity date was extended to February 5, 2025.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the credit agreement. The agreement includes customary negative and affirmative covenants. The filing notes that the description of the agreement is qualified by reference to the full text attached as Exhibit 99.1. No specific guidance, risk factors, or unusual items regarding operational performance are disclosed in this specific filing.
Key Facts for Investor Verification
- Verify the total available liquidity under the new $250 million revolving facility and $100 million term loan.
- Confirm the current utilization rates of these facilities to assess immediate liquidity needs.
- Review the specific definitions of the "Maximum Total Leverage Ratio" in the full agreement to understand interest rate triggers.
- Check for any subsequent filings regarding the actual drawdown of the delayed-draw term loan by the August 6, 2021 deadline.